Related Articles
Inhibition of urokinase‑type plasminogen activator expression by dihydroartemisinin in breast cancer cells
Dihydroartemisinin inhibits the migration of esophageal cancer cells by inducing autophagy
Dihydroartemisinin attenuates lipopolysaccharide‑induced acute lung injury in mice by suppressing NF‑κB signaling in an Nrf2‑dependent manner
Dihydroartemisinin-induced apoptosis in human acute monocytic leukemia cells
In vitro and in vivo inhibition of tumor cell viability by combined dihydroartemisinin and doxorubicin treatment, and the underlying mechanism